These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 26222142)

  • 1. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
    PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
    Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC
    BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
    Peter JG; Theron G; Muchinga TE; Govender U; Dheda K
    PLoS One; 2012; 7(7):e39966. PubMed ID: 22815718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
    Zijenah LS; Kadzirange G; Bandason T; Chipiti MM; Gwambiwa B; Makoga F; Chungu P; Kaguru P; Dheda K
    BMC Infect Dis; 2016 Jan; 16():20. PubMed ID: 26797499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Walensky RP; Freedberg KA; Bassett IV
    BMC Infect Dis; 2014 Feb; 14():110. PubMed ID: 24571362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
    Shah M; Variava E; Holmes CB; Coppin A; Golub JE; McCallum J; Wong M; Luke B; Martin DJ; Chaisson RE; Dorman SE; Martinson NA
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):145-51. PubMed ID: 19692904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.
    Dheda K; Davids V; Lenders L; Roberts T; Meldau R; Ling D; Brunet L; van Zyl Smit R; Peter J; Green C; Badri M; Sechi L; Sharma S; Hoelscher M; Dawson R; Whitelaw A; Blackburn J; Pai M; Zumla A
    PLoS One; 2010 Mar; 5(3):e9848. PubMed ID: 20352098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.
    Nakiyingi L; Moodley VM; Manabe YC; Nicol MP; Holshouser M; Armstrong DT; Zemanay W; Sikhondze W; Mbabazi O; Nonyane BA; Shah M; Joloba ML; Alland D; Ellner JJ; Dorman SE
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):270-9. PubMed ID: 24675585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.
    Nakiyingi L; Bwanika JM; Kirenga B; Nakanjako D; Katabira C; Lubega G; Sempa J; Nyesiga B; Albert H; Manabe YC
    PLoS One; 2013; 8(9):e74023. PubMed ID: 24040151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
    Shah M; Ssengooba W; Armstrong D; Nakiyingi L; Holshouser M; Ellner JJ; Joloba M; Manabe YC; Dorman SE
    AIDS; 2014 Jun; 28(9):1307-14. PubMed ID: 24637544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
    BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial.
    Naidoo P; Esmail A; Peter JG; Davids M; Fadul M; Dheda K
    Int J Infect Dis; 2019 Feb; 79():37-43. PubMed ID: 30292891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Bassett IV
    BMC Pulm Med; 2016 Nov; 16(1):147. PubMed ID: 27842535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.